BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9753249)

  • 1. Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori.
    Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):192S-197S. PubMed ID: 9753249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
    Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
    Dig Dis Sci; 1998 Feb; 43(2):235-40. PubMed ID: 9512112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage.
    Choi KW; Lee YC; Chung IS; Lee JJ; Chung MH; Kim NY; Kim SW; Kim JG; Roe IH; Lee SW; Jung HY; Choi MG; Hahm KB; Hong WS; Kim JH
    Dig Dis Sci; 2002 Feb; 47(2):283-91. PubMed ID: 11855542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
    Hahm KB; Kim DH; Lee KM; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Joo HJ; Cho YK; Nam KT; Cho SW
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():24-38. PubMed ID: 12925138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
    Hahm KB; Lee KJ; Kim JH; Cho SW; Chung MH
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):72S-77S. PubMed ID: 9753230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection.
    Hahm KB; Lee KJ; Choi SY; Kim JH; Cho SW; Yim H; Park SJ; Chung MH
    Am J Gastroenterol; 1997 Oct; 92(10):1853-7. PubMed ID: 9382051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication.
    Felley CP; Pignatelli B; Van Melle GD; Crabtree JE; Stolte M; Diezi J; Corthesy-Theulaz I; Michetti P; Bancel B; Patricot LM; Ohshima H; Felley-Bosco E
    Helicobacter; 2002 Dec; 7(6):342-8. PubMed ID: 12485120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
    Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
    J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
    Kim J; Kim K; Lee JS; Kim SY; Kim KO; Kim YJ; Kwon KA; Park DK; Chung JW
    Korean J Gastroenterol; 2018 Apr; 71(4):204-212. PubMed ID: 29684969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa.
    Pignatelli B; Bancel B; Plummer M; Toyokuni S; Patricot LM; Ohshima H
    Am J Gastroenterol; 2001 Jun; 96(6):1758-66. PubMed ID: 11419826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
    Higuchi K; Arakawa T; Nebiki H; Uchida T; Fujiwara Y; Ando K; Yamasaki K; Takaishi O; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):99S-106S. PubMed ID: 9753234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial.
    Kim CG; Song HJ; Kook MC; Hong EK; Park S; Lee JY; Lee JH; Ryu KW; Kim YW; Bae JM; Choi IJ
    Am J Gastroenterol; 2008 Jan; 103(1):48-54. PubMed ID: 17714557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
    Konturek PC; Kania J; Gessner U; Konturek SJ; Hahn EG; Konturek JW
    Eur J Pharmacol; 2004 Dec; 506(2):169-77. PubMed ID: 15588738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Protects against Helicobacter pylori-Associated Gastritis by Combating Oxidative Stress.
    Zhang X; Jiang A; Qi B; Ma Z; Xiong Y; Dou J; Wang J
    Int J Mol Sci; 2015 Nov; 16(11):27757-69. PubMed ID: 26610474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Nishizawa T; Nishizawa Y; Yahagi N; Kanai T; Takahashi M; Suzuki H
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():20-4. PubMed ID: 25521728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Mucosal Oxidative Stress Markers in Children with Helicobacter Pylori Infection.
    Hagag AA; Amin SM; Emara MH; Abo-Resha SE
    Infect Disord Drug Targets; 2018; 18(1):60-67. PubMed ID: 28464776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
    Kim H; Seo JY; Kim KH
    Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.